Dj. West et Gb. Calandra, VACCINE-INDUCED IMMUNOLOGICAL MEMORY FOR HEPATITIS-B SURFACE-ANTIGEN - IMPLICATIONS FOR POLICY ON BOOSTER VACCINATION, Vaccine, 14(11), 1996, pp. 1019-1027
This paper reviews published literature on the long-term persistence o
f immunologic memory for HBsAg after a course of hepatitis B vaccine a
nd the functional significance this has for policy on booster vaccinat
ion. Several studies have shown that vaccine induced antibody (anti-HB
s) specific for the surface antigen (HBsAg) of hepatitis B virus (HBV)
is protective at a serum concentration of 10 milli-International Unit
s per milliliter (mIU ml(-1)). When acquired passively (e.g. from hepa
titis B immune globulin), susceptibility to infection returns as antib
ody declines. However, vaccine induces active synthesis of anti-HBs ac
companied by immunologic memory for HBsAg that affords ongoing protect
ion independent of antibody. Persistent memory over periods of 5 years
or more is evident from large, rapid increases in antibody following
booster vaccination, even in subjects who have lost antibody. Compleme
ntary studies, using an in vitro enzyme linked immunosorbent assay (sp
ot-ELISA), show that the number of memory B lymphocytes able to produc
e anti-HBs does not diminish as the level of antibody declines. That i
mmunologic memory provides effective immunity is suggested by serologi
c studies over periods of 5 years or more of vaccinees frequently expo
sed to HBV. Although many failed to maintain at least 10 mIU ml(-1) of
antibody, there have been very few clinically significant breakthroug
h infections. Thus, it appears unnecessary to give healthy vaccinees a
booster vaccination when the level of anti-HBs fall below 10 mIU ml(-
1). Current studies suggest good retention of immunologic memory in he
althy vaccinees over periods of 5-12 years. While additional studies w
ill better define the limits of this phenomenon, routine booster vacci
nation should not be needed to sustain immunologic memory and protecti
on within 5 years and perhaps longer after the primary vaccination ser
ies. Copyright (C) 1996 Elsevier Science Ltd.